Daiken Medical Co., Ltd. (7775) Stock Forecast & Analysis

Real-time stock price, financial statements, consensus target price, insider trading, and technical analysis for Daiken Medical Co., Ltd. (7775:JPX), powered by AI.

Current Price
¥420
P/E Ratio
11.0
Market Cap
12.1B
Sector
Healthcare
What is the Daiken Medical Co., Ltd. stock price forecast?

Daiken Medical Co., Ltd. is currently trading at ¥420. View real-time AI analysis on Alpha Lenz.

What is Daiken Medical Co., Ltd. insider trading activity?

View the latest insider trading data for Daiken Medical Co., Ltd. on Alpha Lenz.

What is Daiken Medical Co., Ltd.'s P/E ratio?

Daiken Medical Co., Ltd.'s P/E ratio is 11.0.

Daiken Medical Co., Ltd.

JPX · 7775
¥420+3(+0.72%)Market closedJPX regular session 09:00–15:00 JST
Ask about Daiken Medical Co., Ltd.'s future dividend policy...
Alpha Chat Insight

Daiken Medical Co., Ltd. trades at a P/E of 11.0 (undervalued) with strong ROE of 15.1%.

Ask for details

Company Overview

Daiken Medical Co., Ltd. is a pioneering manufacturer and supplier in the field of medical devices. The company's primary function centers around creating innovative medical solutions that enhance healthcare outcomes. With a broad portfolio, Daiken Medical is particularly noted for producing enteral nutrition products and medical infusion devices, crucial for patient care in hospitals and clinics. These products serve essential roles in supporting the nutrition and medication administration needs in medical settings, affecting various sectors such as hospitals, clinics, and home care. As a significant player in the healthcare industry, Daiken Medical Co., Ltd. contributes to advancements in patient care by offering reliable, safe, and high-quality medical devices. The company has a strong presence in the global market, driven by its commitment to innovation and meeting stringent regulatory standards. By focusing on improving the quality of life for patients, Daiken Medical plays a vital role in the overall healthcare ecosystem, supporting medical professionals in providing effective and efficient patient care.

CEOMr. Keiichi Yamada
SectorHealthcare
IndustryMedical Instruments & Supplies
Employees180

Company Statistics

FY 2025

Profile

¥12,065,943,540Market Cap
¥9,951,701,000Revenue
0.00Shares Out
180Employees

Margins

41.17%Gross
17.57%EBITDA
15.19%Operating
15.16%Pre-Tax
11.03%Net

Valuation

10.99P/E
1.61P/B
1.21EV/Sales
6.35EV/EBITDA
12.66P/FCF

Growth (CAGR)

5.23%Rev 3Yr
3.15%Rev 5Yr
9.53%Op Inc 3Yr
4.83%Op Inc 5Yr
9.72%Net Inc 3Yr
5.01%Net Inc 5Yr

Returns

9.89%ROA
15.10%ROE
13.68%ROIC

Financial Health

¥2,995,993,000Cash & Cash Equivalents
¥669,099,000Net Debt
48.76%Debt/Equity
N/AInterest Cov

Frequently Asked Questions

Daiken Medical Co., Ltd. (ticker: 7775) is a company listed on JPX in the Healthcare sector (Medical Instruments & Supplies). It has approximately 180 employees. Market cap is $12.1B.

The current price is 420 with a P/E ratio of 10.99x and P/B of 1.61x.

ROE is 15.10% and operating margin is 15.19%. Annual revenue is $10.0B.

Alpha Lenz
Singapore
Treasurer Pte Ltd | License: 202346277E
9 Straits View Marina One West Tower #05-07 Singapore 018937
contact@treasurer.co.kr
©2026 Treasurer Pte Ltd. All rights reserved.
Daiken Medical Co., Ltd. (7775) Stock Forecast 2026 ¥420 — Price, Financials & Analyst Targets | Alpha Lenz